Search & Analyze
Popular Searches
Q-Line Biotech Ltd.
Healthcare₹498.90
CMP₹498.90
Mkt Cap₹1.16K Cr
P/E20.89
P/B5.50
ROE13.94%
52W High₹0.00
52W Low₹0.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
20.89
P/B Ratio
5.50
EV/EBITDA
12.37
Price/Sales
3.41
Dividend Yield (%)
0.00
EPS (TTM ₹)
23.89
Book Value (₹)
90.75
ROE (%)
13.94
ROCE (%)
19.19
ROA (%)
6.18
EBITDA Margin (%)
23.74
Net Profit Margin (%)
7.81
Debt/Equity
0.88
Current Ratio
1.48
Interest Coverage
3.98
Asset Turnover
0.79
Working Capital/Sales
3.67
Core EBITDA Growth (%)
103.82
P&L
| Particulars | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|
| Gross Sales | 18273.63 | 20364.61 | 31378.04 |
| Net Sales | 18273.63 | 20364.61 | 31378.04 |
| Total Income | 18481.15 | 20644.81 | 32258.42 |
| Total Expenditure | 14898.5 | 16558.35 | 23929.3 |
| Operating Profit | 3582.65 | 4086.46 | 8329.12 |
| Depreciation | 213.75 | 392.77 | 732.12 |
| Exceptional Items | — | — | -1696.52 |
| Profit Before Tax | 2984.01 | 3060.17 | 4419.23 |
| Tax | 845.76 | 895.96 | 1967.86 |
| Profit After Tax (PAT) | 2138.25 | 2164.21 | 2451.37 |
| EPS (₹) | 20.38 | 21.87 | 28.63 |
| Dividend Payout % | — | — | — |
Balance Sheet
| Particulars | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|
| Share Capital | 157.5 | 157.5 | 157.5 |
| Reserves | 12579.02 | 16023.94 | 18837.03 |
| Shareholders Funds | 12736.52 | 16181.44 | 18994.53 |
| Total Debt | 7364.84 | 9691 | 16629.46 |
| Total Liabilities | 25087.24 | 33866.82 | 45450.5 |
| Total Assets | 25087.24 | 33866.82 | 45450.5 |
| Book Value / Share | 808.6679 | 1027.393 | 1206.0019 |
| Assets | 25087.24 | 33866.82 | 45450.5 |
Cash Flows
| Particulars | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|
| Operating Activities | 2496.86 | -2417.94 | -128.45 |
| Investing Activities | -2631.39 | -4468.78 | -5913 |
| Financing Activities | 2640.35 | 1698.64 | 5333.98 |
| Net Cash Flow | 2505.82 | -5188.08 | -707.47 |
QLINE
₹498.90
+0%